In April 2022, Dotmatics was introduced as the formal name and brand for the combined entities of Insightful Science and Dotmatics. “I've always appreciated having the stats calculated without the need for other applications or computations." “Prism is widely used across all levels of the biotech/pharma industry, while also continuing to improve upon existing features and implementing new functions,” said Thomas Cayton, Associate Scientist at GPCR. “I see tremendous value in Prism being integrated with other lab technologies.” Edwards, Ph.D, Advisor at Afton Chemical. “Prism is the only easy-to-use nonlinear regression analysis software on the market,” said David R. The new Dotmatics integration offers the ability to:Įxport aggregated assay data from multiple experiments to Prism-allows users to skip time-consuming and error-prone manual collating of data by copy and pasteĮxport assays from a single screening experiment to Prism-take a deeper dive to perform advanced statistical analysis and high-fidelity data visualizationsĬreate Prism templates with preset analyses and graphs-provides a user-friendly, no-code method to automate and standardize data analyses and visualization in Prism ![]() This saves hours of time manually exporting, formatting, and importing data into Prism and then performing the calculations and generating required charts. By using a template, they will automatically perform statistical calculations and generate charts of the data. With the integration, the scientist can export the individual experiment data, with or without a Prism template, directly into Prism. For an organization, this means accelerated drug discovery programs where decisions are made faster, relying on higher quality data.įor example, a scientist using Dotmatics screening tool may want to analyze data from a new assay using statistical calculations that are not available in the tool, and also produce high quality charts for a presentation. ![]() It also enhances data quality by eliminating the need for labor-intensive, manual manipulation of data. The integration can save scientists significant time, both in gathering data, particularly when collating across experiments, as well as in performing the analyses by using Prism templates. “Dotmatics is the first and only R&D platform to offer integration with Prism, enabling scientific organizations to save time, accelerate research, and promote higher quality data. It is another step forward in our vision to combine the functionality and power of many of the industry’s favorite applications into an end-to-end platform, creating solutions that can help our customers transform their scientific R&D.” “Prism is beloved by our customers because it’s a versatile statistics tool built for scientists, not statisticians,” said Kalim Saliba, Chief Product Officer. Users can create Prism templates with preset analyses and graphs, making it easier to export data from Dotmatics ELN and screening tools using a standardized method.This integration provides scientists with an easy-to-use, reproducible, no-code method to create publication-quality graphs. ![]() Helps scientific organizations accelerate drug discovery programs by easily exporting large assay sets with faster decision making, using higher quality dataīoston, MA, February 8, 2022– Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced integration between its scientific R&D platform and its GraphPad Prism product, the world's leading analysis and graphing solution for scientific research.Now, scientists and researchers can export assay data directly to Prism from the latest release of the Dotmatics' cloud-based platform, a critical step towards ensuring that all information shared meets FAIR data principles.
0 Comments
Leave a Reply. |